Abstract
Web-based survey data collection has become increasingly popular, and limitations on in-person data collection during the COVID-19 pandemic have fueled this growth. However, the anonymity of the online environment increases the risk of fraud, which pose major risks to data integrity. As part of a study of COVID-19 and the return to in-person school, we implemented a web-based survey of parents in Maryland, USA, between December 2021 and July 2022. Recruitment relied, in part, on social media advertisements. Despite implementing many existing best practices, the survey was challenged by sophisticated fraudsters. In this paper, we describe efforts to identify and prevent fraudulent online survey responses and provide specific, actionable recommendations for identifying and preventing online survey fraud. Some strategies can be deployed within the web-based data collection platform such as Internet Protocol address logging to identify duplicate responses and comparison of client-side and server-side time stamps to identify responses that may have been completed by respondents outside of the survey’s target geography. Additional approaches include the use of a 2-stage survey design, repeated within-survey and cross-survey validation questions, the addition of “speed bump” questions to thwart careless or computerized responders, and the use of optional open-ended survey responses to identify irrelevant responses. We describe best practices for ongoing survey data review and verification, including algorithms to simplify aspects of this review.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the National Institutes of Health, Office of the Director, National Institute of Child Health and Human Development (NICHD), RADx-UP Return to School Diagnostic Testing Approaches (Award #OT2HD108110). The funder had no role in the design of the study and collection, analysis, or interpretation of data.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the Johns Hopkins School of Medicine Institutional Review Board (IRB00290237) and participants provided informed consent. This study was conducted in accordance with the Declaration of Helsinki.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Not Applicable
Data Availability
The survey datasets generated and/or analyzed during the current study are available as part of the NIH RADx-UP Project. For more information regarding data availability, see https://myhome.radx-up.org/cdcc-resources/data-toolkit/